SCHEMBL29974598

SCHEMBL29974598

O=c1cc(Cl)c2cc(Cl)c(Br)c(F)c2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 1/20 0.42
MAPT P10636 1/20 0.36
AR P10275 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NOS2 P35228 5/20 0.33
GRIN2D O15399 3/20 0.32
GRIN3B O60391 3/20 0.32
GRIN1 Q05586 3/20 0.32
GRIN2A Q12879 3/20 0.32
GRIN2B Q13224 3/20 0.32
GRIN2C Q14957 3/20 0.32
GRIN3A Q8TCU5 3/20 0.32
NOS3 P29474 4/20 0.31
NOS1 P29475 4/20 0.31
PDPK1 O15530 1/20 0.31
DAO P14920 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27164027 1.00 EIF4A3 (0.42) EIF4A3MAPTARKDM4ENOS2
SCHEMBL25989272 0.85 MEN1 (0.39) EIF4A3MAPTARKDM4ENOS2
SCHEMBL9775929 0.79 EIF4A3 (0.41) EIF4A3MAPTARKDM4ENOS2
SCHEMBL29388927 0.78 IDH1 (0.36) EIF4A3MAPTKDM4EGRIN2DGRIN3B
SCHEMBL16637455 0.78 IDH1 (0.36) EIF4A3MAPTKDM4EGRIN2DGRIN3B
SCHEMBL24717492 0.76 ALDH1A1 (0.35) EIF4A3MAPTKDM4EGRIN2DGRIN3B
SCHEMBL30077845 0.76 F2 (0.34) EIF4A3
SCHEMBL18128491 0.76 F2 (0.34) EIF4A3
SCHEMBL29153580 0.73 EIF4A3 (0.30) EIF4A3
SCHEMBL25433555 0.71 MAPT (0.38) MAPTARKDM4EGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329888-A1 2-AMINOBENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF Amgen Inc. (US) 2024-03-06 EP disclosed
CN-117651700-A 2-aminobenzothiazole compounds and methods of use 安进公司 2024-03-05 CN disclosed
WO-2022232332-A1 2-AMINOBENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF AMGEN INC. (US) 2022-11-03 WO disclosed